サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1559190

セボフルラン麻酔薬の世界市場の考察、予測（～2030年）

Global Sevoflurane Anesthesia Drugs Market Insights, Forecast to 2030

出版日
発行
QYResearch
ページ情報
英文 163 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
セボフルラン麻酔薬の世界市場の考察、予測（～2030年）
出版日: 2024年09月24日
発行: QYResearch
ページ情報: 英文 163 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセボフルラン麻酔薬の市場規模は、2024年の12億6,203万米ドルから2030年までに16億1,253万米ドルに達すると予測され、予測期間にCAGRで4.17%の成長が見込まれます。

米国・カナダの市場規模は、2024年の3億1,013万米ドルから2030年までに3億7,962万米ドルに達すると推定され、2024年～2030年の予測期間のCAGRは3.43%です。

中国の市場規模は、2024年の5億2,587万米ドルから2030年までに7億644万米ドルに達すると推定され、予測期間のCAGRは5.04％です。

世界のセボフルラン麻酔薬の主要メーカーは、Hengrui、Baxter、Maruishi、AbbVie、Piramal、PT Novell Pharmaceutical、Lunan Pharmaなどです。2023年、世界の上位5社の収益シェアは約91.92%でした。

当レポートでは、世界のセボフルラン麻酔薬市場について調査分析し、売上、収益、市場シェア、主要メーカーのランキングなどの情報を提供しています。

目次

第1章 調査範囲

  • セボフルラン麻酔薬製品のイントロダクション
  • 市場：タイプ別
    • 世界のセボフルラン麻酔薬の市場規模成長率：タイプ別（2019年・2023年・2030年）
    • 250ml/ボトル
    • 100ml/ボトル
  • 市場：用途別
    • 世界のセボフルラン麻酔薬の市場規模成長率：用途別（2019年・2023年・2030年）
    • 病院
    • 診療所
  • 前提条件と制限
  • 調査目的
  • 考慮される年数

第2章 エグゼクティブサマリー

  • 世界のセボフルラン麻酔薬の収益の推計と予測（2019年～2030年）
  • 世界のセボフルラン麻酔薬の収益：地域別
    • 世界のセボフルラン麻酔薬の収益：地域別（2019年・2023年・2030年）
    • 世界のセボフルラン麻酔薬の収益：地域別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益：地域別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の収益の市場シェア：地域別（2019年～2030年）
  • 世界のセボフルラン麻酔薬の売上の推計と予測（2019年～2030年）
  • 世界のセボフルラン麻酔薬の売上：地域別
    • 世界のセボフルラン麻酔薬の売上：地域別（2019年・2023年・2030年）
    • 世界のセボフルラン麻酔薬の売上：地域別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の売上：地域別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の売上の市場シェア：地域別（2019年～2030年）
  • 北米
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東・アフリカ・ラテンアメリカ

第3章 各メーカーの競合

  • 世界のセボフルラン麻酔薬の売上：メーカー別
    • 世界のセボフルラン麻酔薬の売上：メーカー別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の売上の市場シェア：メーカー別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益：メーカー別（2023年）
  • 世界のセボフルラン麻酔薬の収益：メーカー別
    • 世界のセボフルラン麻酔薬の収益：メーカー別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益の市場シェア：メーカー別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益の主要企業（2023年）
  • 世界のセボフルラン麻酔薬の主要企業、業界ランキング（2022年・2023年）
  • 世界のセボフルラン麻酔薬の販売価格：メーカー別（2019年～2024年）
  • 競合情勢の分析
    • メーカーの市場集中度（CR5、HHI）
    • 世界のセボフルラン麻酔薬の市場：企業タイプ別（Tier 1、Tier 2、Tier 3）
  • 世界のセボフルラン麻酔薬の主要メーカー、製造拠点の分布と本社
  • 世界のセボフルラン麻酔薬の主要メーカー、製品
  • 世界のセボフルラン麻酔薬の主要メーカー、設立日
  • 合併と買収、拡張計画

第4章 市場規模：タイプ別

  • 世界のセボフルラン麻酔薬の売上：タイプ別
    • 世界のセボフルラン麻酔薬の売上の売上：タイプ別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の売上の売上：タイプ別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の売上の市場シェア：タイプ別（2019年～2030年）
  • 世界のセボフルラン麻酔薬の収益：タイプ別
    • 世界のセボフルラン麻酔薬の収益の実績：タイプ別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益の予測：タイプ別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の収益の市場シェア：タイプ別（2019年～2030年）
  • 世界のセボフルラン麻酔薬の価格：タイプ別
    • 世界のセボフルラン麻酔薬の価格：タイプ別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の価格の予測：タイプ別（2025年～2030年）

第5章 市場規模：用途別

  • 世界のセボフルラン麻酔薬の売上：用途別
    • 世界のセボフルラン麻酔薬の売上の実績：用途別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の売上の予測：用途別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の売上の市場シェア：用途別（2019年～2030年）
  • 世界のセボフルラン麻酔薬の収益：用途別
    • 世界のセボフルラン麻酔薬の収益の実績：用途別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の収益の予測：用途別（2025年～2030年）
    • 世界のセボフルラン麻酔薬の収益の市場シェア：用途別（2019年～2030年）
  • 世界のセボフルラン麻酔薬の価格：用途別
    • 世界のセボフルラン麻酔薬の価格：用途別（2019年～2024年）
    • 世界のセボフルラン麻酔薬の価格の予測：用途別（2025年～2030年）

第6章 北米

  • 北米のセボフルラン麻酔薬の市場規模：タイプ別
    • 北米のセボフルラン麻酔薬の売上の内訳：タイプ別（2019年～2030年）
    • 北米のセボフルラン麻酔薬の収益：タイプ別（2019年～2030年）
  • 北米のセボフルラン麻酔薬の市場規模：用途別
    • 北米のセボフルラン麻酔薬の売上：用途別（2019年～2030年）
    • 北米のセボフルラン麻酔薬の収益：用途別（2019年～2030年）
  • 北米のセボフルラン麻酔薬の市場規模：国別
    • 北米のセボフルラン麻酔薬の収益：国別（2019年・2023年・2030年）
    • 北米のセボフルラン麻酔薬の収益：国別（2019年～2030年）
    • 北米のセボフルラン麻酔薬の売上：国別（2019年～2030年）
    • 米国
    • カナダ

第7章 欧州

  • 欧州のセボフルラン麻酔薬の市場規模：タイプ別
    • 欧州のセボフルラン麻酔薬の売上：タイプ別（2019年～2030年）
    • 欧州のセボフルラン麻酔薬の収益：タイプ別（2019年～2030年）
  • 欧州のセボフルラン麻酔薬の市場規模：用途別
    • 欧州のセボフルラン麻酔薬の売上：用途別（2019年～2030年）
    • 欧州のセボフルラン麻酔薬の収益：用途別（2019年～2030年）
  • 欧州のセボフルラン麻酔薬の市場規模：国別
    • 欧州のセボフルラン麻酔薬の収益：国別（2019年・2023年・2030年）
    • 欧州のセボフルラン麻酔薬の収益：国別（2019年～2030年）
    • 欧州のセボフルラン麻酔薬の売上：国別（2019年～2030年）
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国のセボフルラン麻酔薬の市場規模：タイプ別
    • 中国のセボフルラン麻酔薬の売上の内訳：タイプ別（2019年～2030年）
    • 中国のセボフルラン麻酔薬の収益：タイプ別（2019年～2030年）
  • 中国のセボフルラン麻酔薬の市場規模：用途別
    • 中国のセボフルラン麻酔薬の売上：用途別（2019年～2030年）
    • 中国のセボフルラン麻酔薬の収益：用途別（2019年～2030年）

第9章 アジア（中国以外）

  • アジアのセボフルラン麻酔薬の市場規模：タイプ別
    • アジアのセボフルラン麻酔薬の売上の内訳：タイプ別（2019年～2030年）
    • アジアのセボフルラン麻酔薬の収益：タイプ別（2019年～2030年）
  • アジアのセボフルラン麻酔薬の市場規模：用途別
    • アジアのセボフルラン麻酔薬の売上：用途別（2019年～2030年）
    • アジアのセボフルラン麻酔薬の収益：用途別（2019年～2030年）
  • アジアのセボフルラン麻酔薬の市場規模：地域別
    • アジアのセボフルラン麻酔薬の収益：地域別（2019年・2023年・2030年）
    • アジアのセボフルラン麻酔薬の収益：地域別（2019年～2030年）
    • アジアのセボフルラン麻酔薬の売上：地域別（2019年～2030年）
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東・アフリカ・ラテンアメリカ

  • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の市場規模：タイプ別
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の売上：タイプ別（2019年～2030年）
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の収益：タイプ別（2019年～2030年）
  • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の市場規模：用途別
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の売上：用途別（2019年～2030年）
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の収益：用途別（2019年～2030年）
  • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の市場規模：国別
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の収益：国別（2019年・2023年・2030年）
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の収益：国別（2019年～2030年）
    • 中東・アフリカ・ラテンアメリカのセボフルラン麻酔薬の売上：国別（2019年～2030年）
    • ブラジル
    • メキシコ
    • 中東
    • アフリカ

第11章 企業プロファイル

  • Hengrui
  • Baxter
  • Maruishi
  • AbbVie
  • Piramal
  • PT Novell Pharmaceutical
  • Lunan Pharma
  • Hana Pharm
  • Hebei Yipin Pharmaceutical

第12章 産業チェーンと販売チャネルの分析

  • セボフルラン麻酔薬の産業チェーン分析
  • セボフルラン麻酔薬の主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • セボフルラン麻酔薬の生産方式とプロセス
  • セボフルラン麻酔薬の販売とマーケティング
    • セボフルラン麻酔薬の販売チャネル
    • セボフルラン麻酔薬の販売業者
  • セボフルラン麻酔薬の顧客

第13章 セボフルラン麻酔薬の市場力学

    • セボフルラン麻酔薬産業の動向
    • セボフルラン麻酔薬市場の促進要因
    • セボフルラン麻酔薬市場の課題
    • セボフルラン麻酔薬市場の抑制要因

第14章 世界のセボフルラン麻酔薬研究における主な調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of 250ml/Bottle
  • Table 3. Major Manufacturers of 100ml/Bottle
  • Table 4. Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 5. Global Sevoflurane Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 6. Global Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024) & (US$ Million)
  • Table 7. Global Sevoflurane Anesthesia Drugs Revenue by Region (2025-2030) & (US$ Million)
  • Table 8. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2019-2024)
  • Table 9. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2025-2030)
  • Table 10. Global Sevoflurane Anesthesia Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
  • Table 11. Global Sevoflurane Anesthesia Drugs Sales by Region (2019-2024) & (K Units)
  • Table 12. Global Sevoflurane Anesthesia Drugs Sales by Region (2025-2030) & (K Units)
  • Table 13. Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2019-2024)
  • Table 14. Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2025-2030)
  • Table 15. Global Sevoflurane Anesthesia Drugs Sales by Manufacturers (2019-2024) & (K Units)
  • Table 16. Global Sevoflurane Anesthesia Drugs Sales Share by Manufacturers (2019-2024)
  • Table 17. Global Sevoflurane Anesthesia Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 18. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
  • Table 19. Global Key Players of Sevoflurane Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2023
  • Table 20. Sevoflurane Anesthesia Drugs Price by Manufacturers (2019-2024) & (US$/Unit)
  • Table 21. Global Sevoflurane Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Sevoflurane Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane Anesthesia Drugs as of 2023)
  • Table 23. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Product Offered
  • Table 25. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Founded Date
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 28. Global Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 29. Global Sevoflurane Anesthesia Drugs Sales Share by Type (2019-2024)
  • Table 30. Global Sevoflurane Anesthesia Drugs Sales Share by Type (2025-2030)
  • Table 31. Global Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 32. Global Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 33. Global Sevoflurane Anesthesia Drugs Revenue Share by Type (2019-2024)
  • Table 34. Global Sevoflurane Anesthesia Drugs Revenue Share by Type (2025-2030)
  • Table 35. Sevoflurane Anesthesia Drugs Price by Type (2019-2024) & (US$/Unit)
  • Table 36. Global Sevoflurane Anesthesia Drugs Price Forecast by Type (2025-2030) & (US$/Unit)
  • Table 37. Global Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 38. Global Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 39. Global Sevoflurane Anesthesia Drugs Sales Share by Application (2019-2024)
  • Table 40. Global Sevoflurane Anesthesia Drugs Sales Share by Application (2025-2030)
  • Table 41. Global Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 42. Global Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 43. Global Sevoflurane Anesthesia Drugs Revenue Share by Application (2019-2024)
  • Table 44. Global Sevoflurane Anesthesia Drugs Revenue Share by Application (2025-2030)
  • Table 45. Sevoflurane Anesthesia Drugs Price by Application (2019-2024) & (US$/Unit)
  • Table 46. Global Sevoflurane Anesthesia Drugs Price Forecast by Application (2025-2030) & (US$/Unit)
  • Table 47. North America Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 48. North America Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 49. North America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 50. North America Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 51. North America Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 52. North America Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 53. North America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 54. North America Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 55. North America Sevoflurane Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 56. North America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 57. North America Sevoflurane Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 58. North America Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
  • Table 59. North America Sevoflurane Anesthesia Drugs Sales by Country (2025-2030) & (K Units)
  • Table 60. Europe Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 61. Europe Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 62. Europe Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 63. Europe Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 64. Europe Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 65. Europe Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 66. Europe Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 67. Europe Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 68. Europe Sevoflurane Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 69. Europe Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 70. Europe Sevoflurane Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 71. Europe Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
  • Table 72. Europe Sevoflurane Anesthesia Drugs Sales by Country (2025-2030) & (K Units)
  • Table 73. China Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 74. China Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 75. China Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 76. China Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 77. China Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 78. China Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 79. China Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 80. China Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 81. Asia Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 82. Asia Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 83. Asia Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 84. Asia Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 85. Asia Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 86. Asia Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 87. Asia Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 88. Asia Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 89. Asia Sevoflurane Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 90. Asia Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024) & (US$ Million)
  • Table 91. Asia Sevoflurane Anesthesia Drugs Revenue by Region (2025-2030) & (US$ Million)
  • Table 92. Asia Sevoflurane Anesthesia Drugs Sales by Region (2019-2024) & (K Units)
  • Table 93. Asia Sevoflurane Anesthesia Drugs Sales by Region (2025-2030) & (K Units)
  • Table 94. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Type (2019-2024) & (K Units)
  • Table 95. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Type (2025-2030) & (K Units)
  • Table 96. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2024) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Type (2025-2030) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
  • Table 99. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Application (2025-2030) & (K Units)
  • Table 100. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2024) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Application (2025-2030) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
  • Table 106. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Country (2025-2030) & (K Units)
  • Table 107. Hengrui Company Information
  • Table 108. Hengrui Description and Major Businesses
  • Table 109. Hengrui Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 110. Hengrui Sevoflurane Anesthesia Drugs Product Introduction
  • Table 111. Hengrui Recent Developments
  • Table 112. Baxter Company Information
  • Table 113. Baxter Description and Major Businesses
  • Table 114. Baxter Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 115. Baxter Sevoflurane Anesthesia Drugs Product Introduction
  • Table 116. Baxter Recent Developments
  • Table 117. Maruishi Company Information
  • Table 118. Maruishi Description and Major Businesses
  • Table 119. Maruishi Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 120. Maruishi Sevoflurane Anesthesia Drugs Product Introduction
  • Table 121. AbbVie Company Information
  • Table 122. AbbVie Description and Major Businesses
  • Table 123. AbbVie Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 124. AbbVie Sevoflurane Anesthesia Drugs Product Introduction
  • Table 125. AbbVie Recent Developments
  • Table 126. Piramal Company Information
  • Table 127. Piramal Description and Major Businesses
  • Table 128. Piramal Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 129. Piramal Sevoflurane Anesthesia Drugs Product Introduction
  • Table 130. PT Novell Pharmaceutical Company Information
  • Table 131. PT Novell Pharmaceutical Description and Major Businesses
  • Table 132. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 133. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
  • Table 134. Lunan Pharma Company Information
  • Table 135. Lunan Pharma Description and Major Businesses
  • Table 136. Lunan Pharma Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 137. Lunan Pharma Sevoflurane Anesthesia Drugs Product Introduction
  • Table 138. Hana Pharm Company Information
  • Table 139. Hana Pharm Description and Major Businesses
  • Table 140. Hana Pharm Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 141. Hana Pharm Sevoflurane Anesthesia Drugs Product Introduction
  • Table 142. Hebei Yipin Pharmaceutical Company Information
  • Table 143. Hebei Yipin Pharmaceutical Description and Major Businesses
  • Table 144. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 145. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
  • Table 146. Hebei Yipin Pharmaceutical Recent Developments
  • Table 147. Key Raw Materials Lists
  • Table 148. Raw Materials Key Suppliers Lists
  • Table 149. Sevoflurane Anesthesia Drugs Distributors List
  • Table 150. Sevoflurane Anesthesia Drugs Customers List
  • Table 151. Sevoflurane Anesthesia Drugs Market Trends
  • Table 152. Sevoflurane Anesthesia Drugs Market Drivers
  • Table 153. Sevoflurane Anesthesia Drugs Market Challenges
  • Table 154. Sevoflurane Anesthesia Drugs Market Restraints
  • Table 155. Research Programs/Design for This Report
  • Table 156. Key Data Information from Secondary Sources
  • Table 157. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Sevoflurane Anesthesia Drugs Product Picture
  • Figure 2. Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Type, 2019-2030 (US$ Million)
  • Figure 3. Global Sevoflurane Anesthesia Drugs Market Share by Type: 2023
  • Figure 4. Global Sevoflurane Anesthesia Drugs Market Share by Type: 2030
  • Figure 5. 250ml/Bottle Product Picture
  • Figure 6. 100ml/Bottle Product Picture
  • Figure 7. Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Application, 2019- 2030 (US$ Million)
  • Figure 8. Global Sevoflurane Anesthesia Drugs Market Share by Application: 2023
  • Figure 9. Global Sevoflurane Anesthesia Drugs Market Share by Application: 2030
  • Figure 10. Hospital
  • Figure 11. Clinic
  • Figure 12. Sevoflurane Anesthesia Drugs Report Years Considered
  • Figure 13. Global Sevoflurane Anesthesia Drugs Revenue, (US$ Million), 2019 VS 2024 VS 2030
  • Figure 14. Global Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 15. Global Sevoflurane Anesthesia Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 16. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 17. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2019-2030)
  • Figure 18. Global Sevoflurane Anesthesia Drugs Sales (2019-2030) & (K Units)
  • Figure 19. Global Sevoflurane Anesthesia Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
  • Figure 20. Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2019-2030)
  • Figure 21. North America Sevoflurane Anesthesia Drugs Sales YoY (2019-2030) & (K Units)
  • Figure 22. North America Sevoflurane Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
  • Figure 23. Europe Sevoflurane Anesthesia Drugs Sales YoY (2019-2030) & (K Units)
  • Figure 24. Europe Sevoflurane Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
  • Figure 25. China Sevoflurane Anesthesia Drugs Sales YoY (2019-2030) & (K Units)
  • Figure 26. China Sevoflurane Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
  • Figure 27. Asia (Ex. China) Sevoflurane Anesthesia Drugs Sales YoY (2019-2030) & (K Units)
  • Figure 28. Asia (Ex. China) Sevoflurane Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
  • Figure 29. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales YoY (2019-2030) & (K Units)
  • Figure 30. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue YoY (2019-2030) & (US$ Million)
  • Figure 31. The Sevoflurane Anesthesia Drugs Market Share of Top Largest Manufacturers Around the World in 2023
  • Figure 32. The Top Largest Manufacturers of Sevoflurane Anesthesia Drugs in the World: Market Share by Sevoflurane Anesthesia Drugs Revenue in 2023
  • Figure 33. Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 34. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 35. Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 36. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 37. North America Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 38. North America Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 39. North America Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 40. North America Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 41. North America Sevoflurane Anesthesia Drugs Revenue Share by Country (2019-2030)
  • Figure 42. North America Sevoflurane Anesthesia Drugs Sales Share by Country (2019-2030)
  • Figure 43. US Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 44. Canada Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 45. Europe Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 46. Europe Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 47. Europe Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 48. Europe Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 49. Europe Sevoflurane Anesthesia Drugs Revenue Share by Country (2019-2030)
  • Figure 50. Europe Sevoflurane Anesthesia Drugs Sales Share by Country (2019-2030)
  • Figure 51. Germany Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 52. France Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 53. U.K. Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 54. Italy Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 55. Russia Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 56. China Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 57. China Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 58. China Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 59. China Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 60. Asia Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 61. Asia Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 62. Asia Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 63. Asia Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 64. Asia Sevoflurane Anesthesia Drugs Revenue Share by Region (2019-2030)
  • Figure 65. Asia Sevoflurane Anesthesia Drugs Sales Share by Region (2019-2030)
  • Figure 66. Japan Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 67. South Korea Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 68. Southeast Asia Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 69. India Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 70. Australia Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 71. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • Figure 72. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • Figure 73. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • Figure 74. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • Figure 75. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue Share by Country (2019-2030)
  • Figure 76. Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales Share by Country (2019-2030)
  • Figure 77. Brazil Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 78. Mexico Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 79. Middle East Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 80. Africa Sevoflurane Anesthesia Drugs Revenue (2019-2030) & (US$ Million)
  • Figure 81. Sevoflurane Anesthesia Drugs Value Chain
  • Figure 82. Sevoflurane Anesthesia Drugs Production Process
  • Figure 83. Channels of Distribution (Direct Vs Distribution)
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

The global Sevoflurane Anesthesia Drugs market is projected to grow from US$ 1262.03 million in 2024 to US$ 1612.53 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.17% during the forecast period.

The United States & Canada market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 310.13 million in 2024 to reach $ 379.62 million by 2030, at a CAGR of 3.43% during the forecast period of 2024 through 2030.

The China market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 525.87 million in 2024 to reach $ 706.44 million by 2030, at a CAGR of 5.04% during the forecast period of 2024 through 2030.

The global key manufacturers of Sevoflurane Anesthesia Drugs include Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc. In 2023, the global top five players had a share approximately 91.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Sevoflurane Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sevoflurane Anesthesia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sevoflurane Anesthesia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sevoflurane Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sevoflurane Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sevoflurane Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc.

Market Segmentation

By Company

  • Hengrui
  • Baxter
  • Maruishi
  • AbbVie
  • Piramal
  • PT Novell Pharmaceutical
  • Lunan Pharma
  • Hana Pharm
  • Hebei Yipin Pharmaceutical

Segment by Type

  • 250ml/Bottle
  • 100ml/Bottle
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

Segment by Region

North America

  • U.S.
  • Canada

China

Asia (Ex. China)

  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Middle East, Africa, Latin America

  • Brazil
  • Mexico
  • Middle East
  • Africa
  • Other

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Sevoflurane Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Sevoflurane Anesthesia Drugs manufacturer's competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (Ex. China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

  • 1.1 Sevoflurane Anesthesia Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 250ml/Bottle
    • 1.2.3 100ml/Bottle
  • 1.3 Market by Application
    • 1.3.1 Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Sevoflurane Anesthesia Drugs Revenue Estimates and Forecasts 2019-2030
  • 2.2 Global Sevoflurane Anesthesia Drugs Revenue by Region
    • 2.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Global Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024)
    • 2.2.3 Global Sevoflurane Anesthesia Drugs Revenue by Region (2025-2030)
    • 2.2.4 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2019-2030)
  • 2.3 Global Sevoflurane Anesthesia Drugs Sales Estimates and Forecasts 2019-2030
  • 2.4 Global Sevoflurane Anesthesia Drugs Sales by Region
    • 2.4.1 Global Sevoflurane Anesthesia Drugs Sales by Region: 2019 VS 2023 VS 2030
    • 2.4.2 Global Sevoflurane Anesthesia Drugs Sales by Region (2019-2024)
    • 2.4.3 Global Sevoflurane Anesthesia Drugs Sales by Region (2025-2030)
    • 2.4.4 Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2019-2030)
  • 2.5 North America
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (Ex. China)
  • 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Sevoflurane Anesthesia Drugs Sales by Manufacturers
    • 3.1.1 Global Sevoflurane Anesthesia Drugs Sales by Manufacturers (2019-2024)
    • 3.1.2 Global Sevoflurane Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
    • 3.1.3 Global Top Largest Manufacturers of Sevoflurane Anesthesia Drugs in 2023
  • 3.2 Global Sevoflurane Anesthesia Drugs Revenue by Manufacturers
    • 3.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Manufacturers (2019-2024)
    • 3.2.2 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
    • 3.2.3 Global Top Companies by Sevoflurane Anesthesia Drugs Revenue in 2023
  • 3.3 Global Key Players of Sevoflurane Anesthesia Drugs, Industry Ranking, 2022 VS 2023
  • 3.4 Global Sevoflurane Anesthesia Drugs Sales Price by Manufacturers (2019-2024)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Sevoflurane Anesthesia Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Product Offered
  • 3.8 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Founded Date
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Sevoflurane Anesthesia Drugs Sales by Type
    • 4.1.1 Global Sevoflurane Anesthesia Drugs Historical Sales by Type (2019-2024)
    • 4.1.2 Global Sevoflurane Anesthesia Drugs Forecasted Sales by Type (2025-2030)
    • 4.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
  • 4.2 Global Sevoflurane Anesthesia Drugs Revenue by Type
    • 4.2.1 Global Sevoflurane Anesthesia Drugs Historical Revenue by Type (2019-2024)
    • 4.2.2 Global Sevoflurane Anesthesia Drugs Forecasted Revenue by Type (2025-2030)
    • 4.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
  • 4.3 Global Sevoflurane Anesthesia Drugs Price by Type
    • 4.3.1 Global Sevoflurane Anesthesia Drugs Price by Type (2019-2024)
    • 4.3.2 Global Sevoflurane Anesthesia Drugs Price Forecast by Type (2025-2030)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Sevoflurane Anesthesia Drugs Sales by Application
    • 5.1.1 Global Sevoflurane Anesthesia Drugs Historical Sales by Application (2019-2024)
    • 5.1.2 Global Sevoflurane Anesthesia Drugs Forecasted Sales by Application (2025-2030)
    • 5.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
  • 5.2 Global Sevoflurane Anesthesia Drugs Revenue by Application
    • 5.2.1 Global Sevoflurane Anesthesia Drugs Historical Revenue by Application (2019-2024)
    • 5.2.2 Global Sevoflurane Anesthesia Drugs Forecasted Revenue by Application (2025-2030)
    • 5.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
  • 5.3 Global Sevoflurane Anesthesia Drugs Price by Application
    • 5.3.1 Global Sevoflurane Anesthesia Drugs Price by Application (2019-2024)
    • 5.3.2 Global Sevoflurane Anesthesia Drugs Price Forecast by Application (2025-2030)

6 NORTH AMERICA

  • 6.1 North America Sevoflurane Anesthesia Drugs Market Size by Type
    • 6.1.1 North America Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
    • 6.1.2 North America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
  • 6.2 North America Sevoflurane Anesthesia Drugs Market Size by Application
    • 6.2.1 North America Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
    • 6.2.2 North America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
  • 6.3 North America Sevoflurane Anesthesia Drugs Market Size by Country
    • 6.3.1 North America Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
    • 6.3.2 North America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
    • 6.3.3 North America Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
    • 6.3.4 US
    • 6.3.5 Canada

7 EUROPE

  • 7.1 Europe Sevoflurane Anesthesia Drugs Market Size by Type
    • 7.1.1 Europe Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
    • 7.1.2 Europe Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
  • 7.2 Europe Sevoflurane Anesthesia Drugs Market Size by Application
    • 7.2.1 Europe Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
    • 7.2.2 Europe Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
  • 7.3 Europe Sevoflurane Anesthesia Drugs Market Size by Country
    • 7.3.1 Europe Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 Europe Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
    • 7.3.3 Europe Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 CHINA

  • 8.1 China Sevoflurane Anesthesia Drugs Market Size by Type
    • 8.1.1 China Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
    • 8.1.2 China Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
  • 8.2 China Sevoflurane Anesthesia Drugs Market Size by Application
    • 8.2.1 China Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
    • 8.2.2 China Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)

9 ASIA (EX. CHINA)

  • 9.1 Asia Sevoflurane Anesthesia Drugs Market Size by Type
    • 9.1.1 Asia Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
    • 9.1.2 Asia Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
  • 9.2 Asia Sevoflurane Anesthesia Drugs Market Size by Application
    • 9.2.1 Asia Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
    • 9.2.2 Asia Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
  • 9.3 Asia Sevoflurane Anesthesia Drugs Market Size by Region
    • 9.3.1 Asia Sevoflurane Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
    • 9.3.2 Asia Sevoflurane Anesthesia Drugs Revenue by Region (2019-2030)
    • 9.3.3 Asia Sevoflurane Anesthesia Drugs Sales by Region (2019-2030)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 Southeast Asia
    • 9.3.7 India
    • 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

  • 10.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
    • 10.1.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
  • 10.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
    • 10.2.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
  • 10.3 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
    • 10.3.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
    • 10.3.3 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Middle East
    • 10.3.7 Africa

11 CORPORATE PROFILE

  • 11.1 Hengrui
    • 11.1.1 Hengrui Company Information
    • 11.1.2 Hengrui Overview
    • 11.1.3 Hengrui Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.1.4 Hengrui Sevoflurane Anesthesia Drugs Product Introduction
    • 11.1.5 Hengrui Recent Developments
  • 11.2 Baxter
    • 11.2.1 Baxter Company Information
    • 11.2.2 Baxter Overview
    • 11.2.3 Baxter Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.2.4 Baxter Sevoflurane Anesthesia Drugs Product Introduction
    • 11.2.5 Baxter Recent Developments
  • 11.3 Maruishi
    • 11.3.1 Maruishi Company Information
    • 11.3.2 Maruishi Overview
    • 11.3.3 Maruishi Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.3.4 Maruishi Sevoflurane Anesthesia Drugs Product Introduction
  • 11.4 AbbVie
    • 11.4.1 AbbVie Company Information
    • 11.4.2 AbbVie Overview
    • 11.4.3 AbbVie Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.4.4 AbbVie Sevoflurane Anesthesia Drugs Product Introduction
    • 11.4.5 AbbVie Recent Developments
  • 11.5 Piramal
    • 11.5.1 Piramal Company Information
    • 11.5.2 Piramal Overview
    • 11.5.3 Piramal Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.5.4 Piramal Sevoflurane Anesthesia Drugs Product Introduction
  • 11.6 PT Novell Pharmaceutical
    • 11.6.1 PT Novell Pharmaceutical Company Information
    • 11.6.2 PT Novell Pharmaceutical Overview
    • 11.6.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.6.4 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
  • 11.7 Lunan Pharma
    • 11.7.1 Lunan Pharma Company Information
    • 11.7.2 Lunan Pharma Overview
    • 11.7.3 Lunan Pharma Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.7.4 Lunan Pharma Sevoflurane Anesthesia Drugs Product Introduction
  • 11.8 Hana Pharm
    • 11.8.1 Hana Pharm Company Information
    • 11.8.2 Hana Pharm Overview
    • 11.8.3 Hana Pharm Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.8.4 Hana Pharm Sevoflurane Anesthesia Drugs Product Introduction
  • 11.9 Hebei Yipin Pharmaceutical
    • 11.9.1 Hebei Yipin Pharmaceutical Company Information
    • 11.9.2 Hebei Yipin Pharmaceutical Overview
    • 11.9.3 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
    • 11.9.4 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
    • 11.9.5 Hebei Yipin Pharmaceutical Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Sevoflurane Anesthesia Drugs Industry Chain Analysis
  • 12.2 Sevoflurane Anesthesia Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Sevoflurane Anesthesia Drugs Production Mode & Process
  • 12.4 Sevoflurane Anesthesia Drugs Sales and Marketing
    • 12.4.1 Sevoflurane Anesthesia Drugs Sales Channels
    • 12.4.2 Sevoflurane Anesthesia Drugs Distributors
  • 12.5 Sevoflurane Anesthesia Drugs Customers

13 SEVOFLURANE ANESTHESIA DRUGS MARKET DYNAMICS

    • 13.1.1 Sevoflurane Anesthesia Drugs Industry Trends
    • 13.1.2 Sevoflurane Anesthesia Drugs Market Drivers
    • 13.1.3 Sevoflurane Anesthesia Drugs Market Challenges
    • 13.1.4 Sevoflurane Anesthesia Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL SEVOFLURANE ANESTHESIA DRUGS STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer